Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates

por Ayaru, L, Stoeber, K, Webster, G J, Hatfield, A R W, Wollenschlaeger, A, Okoturo, O, Rashid, M, Williams, G, Pereira, S P
Publicado 2008

Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model

por Hermes, M, Schormann, W, Brulport, M, Uhlemann, K, Lupatsch, F, Horn, L C, Schumann, A, Allgaier, C, Weishaupt, M, Engeland, K, Müller, G A, Mössner, J, Bauer, A, Schiffer, I B, Gebhard, S, Schmidt, M, Lausch, E, Prawitt, D, Wilhelm, C, Hengstler, J G
Publicado 2008

Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition

por Allen, N E, Key, T J, Appleby, P N, Travis, R C, Roddam, A W, Tjønneland, A, Johnsen, N F, Overvad, K, Linseisen, J, Rohrmann, S, Boeing, H, Pischon, T, Bueno-de-Mesquita, H B, Kiemeney, L, Tagliabue, G, Palli, D, Vineis, P, Tumino, R, Trichopoulou, A, Kassapa, C, Trichopoulos, D, Ardanaz, E, Larrañaga, N, Tormo, M-J, González, C A, Quirós, J R, Sánchez, M-J, Bingham, S, Khaw, K-T, Manjer, J, Berglund, G, Stattin, P, Hallmans, G, Slimani, N, Ferrari, P, Rinaldi, S, Riboli, E
Publicado 2008

Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study

por Awada, A, Albanell, J, Canney, P A, Dirix, L Y, Gil, T, Cardoso, F, Gascon, P, Piccart, M J, Baselga, J
Publicado 2008

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

por Paz-Ares, L, Ross, H, O'Brien, M, Riviere, A, Gatzemeier, U, Von Pawel, J, Kaukel, E, Freitag, L, Digel, W, Bischoff, H, García-Campelo, R, Iannotti, N, Reiterer, P, Bover, I, Prendiville, J, Eisenfeld, A J, Oldham, F B, Bandstra, B, Singer, J W, Bonomi, P
Publicado 2008

Clinical significance of transmembrane 4 superfamily in colon cancer

por Hashida, H, Takabayashi, A, Tokuhara, T, Hattori, N, Taki, T, Hasegawa, H, Satoh, S, Kobayashi, N, Yamaoka, Y, Miyake, M
Publicado 2003

RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma

por Shyu, R-Y, Jiang, S-Y, Chou, J-M, Shih, Y-L, Lee, M-S, Yu, J-C, Chao, P-C, Hsu, Y-J, Jao, S-W
Publicado 2003

Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised c...

por Innes, H E, Smith, D B, O'Reilly, S M, Clark, P I, Kelly, V, Marshall, E
Publicado 2003

First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial

por Bokemeyer, C, Schleucher, N, Metzner, B, Thomas, M, Rick, O, Schmoll, H-J, Kollmannsberger, C, Boehlke, I, Kanz, L, Hartmann, J T
Publicado 2003

In vitro and in vivo effects of easily administered, low-toxic retinoid and phenylacetate compounds on human neuroblastoma cells

por Sidell, N, Pasquali, M, Malkapuram, S, Barua, A B, Wanichkul, T, Wada, R K
Publicado 2003

Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients

por Dong, X-Y, Su, Y-R, Qian, X-P, Yang, X-A, Pang, X-W, Wu, H-Y, Chen, W-F
Publicado 2003

Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines

por van Geelen, C M M, de Vries, E G E, Le, T K P, van Weeghel, R P, de Jong, S
Publicado 2003

Phase 1 study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas

por Newlands, E S, Foster, T, Zaknoen, S
Publicado 2003

Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR–β1 integrin complex i...

por Ahmed, N, Oliva, K, Wang, Y, Quinn, M, Rice, G
Publicado 2003

Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents

por Han, C, Braybrooke, J P, Deplanque, G, Taylor, M, Mackintosh, D, Kaur, K, Samouri, K, Ganesan, T S, Harris, A L, Talbot, D C
Publicado 2003

In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope

por Collingridge, D R, Glaser, M, Osman, S, Barthel, H, Hutchinson, O C, Luthra, S K, Brady, F, Bouchier-Hayes, L, Martin, S J, Workman, P, Price, P, Aboagye, E O
Publicado 2003

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

por Adami, J, Gäbel, H, Lindelöf, B, Ekström, K, Rydh, B, Glimelius, B, Ekbom, A, Adami, H-O, Granath, F
Publicado 2003

Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer

por Chang, B L, Zheng, S L, Isaacs, S D, Turner, A, Hawkins, G A, Wiley, K E, Bleecker, E R, Walsh, P C, Meyers, D A, Isaacs, W B, Xu, J
Publicado 2003

Differential SPARC mRNA expression in Barrett's oesophagus

por Brabender, J, Lord, R V, Metzger, R, Park, J, Salonga, D, Danenberg, K D, Danenberg, P V, Hölscher, A H, Schneider, P M
Publicado 2003

A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer

por Madhusudan, S, Protheroe, A, Propper, D, Han, C, Corrie, P, Earl, H, Hancock, B, Vasey, P, Turner, A, Balkwill, F, Hoare, S, Harris, A L
Publicado 2003